These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

148 related items for PubMed ID: 5726835

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. The influence of various neuroleptic drugs on shock avoidance responding in rats. I. Nondiscriminated Sidman avoidance procedure.
    Niemegeers CJ, Verbruggen FJ, Janssen PA.
    Psychopharmacologia; 1969; 16(3):161-74. PubMed ID: 5364169
    [No Abstract] [Full Text] [Related]

  • 5. [Correlation between antipsychotic and extrapyramidal properties of neuroleptics].
    Filotto J, Bordeleau JM, Tétreault L.
    Union Med Can; 1969 Apr; 98(4):562-6. PubMed ID: 5355787
    [No Abstract] [Full Text] [Related]

  • 6. [Phenamine antagonism as a treat for experimental evaluation of neuroleptics].
    Raevskiĭ KS.
    Farmakol Toksikol; 1973 Apr; 36(2):149-54. PubMed ID: 4151668
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Is there a relationship between the involvement of extrapyramidal and mesolimbic brain areas with the cataleptic action of neuroleptic agents and their clinical antipsychotic effect?
    Costall B, Naylor RJ.
    Psychopharmacologia; 1973 Apr; 32(2):161-70. PubMed ID: 4796282
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [A chronic extrapyramidal syndrome as a complication of neuroleptic therapy].
    Gurovich IIa, Fleĭs EP.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1969 Apr; 69(12):1862-8. PubMed ID: 5375563
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Drug-induced extrapyramidal symptoms: their incidence and treatment.
    Sheppard C, Merlis S.
    Am J Psychiatry; 1967 Jan; 123(7):886-9. PubMed ID: 6016862
    [No Abstract] [Full Text] [Related]

  • 15. Effects of haloperidol and trifluperidol on operant behavior in the rat.
    Monti JM, Hance AJ.
    Psychopharmacologia; 1967 Jan; 12(1):34-43. PubMed ID: 6081326
    [No Abstract] [Full Text] [Related]

  • 16. Trifluperidol and cholesterol in man.
    Clark ML, Braun GA, Hewson JR, Serafetinides EA, Colmore JP, Rahhal DK.
    Clin Pharmacol Ther; 1968 Jan; 9(3):333-40. PubMed ID: 4870255
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [On the question of possible irreversible disorders due to psychopharmacotherapy].
    Meyer HH.
    Arch Psychiatr Nervenkr (1970); 1966 Jan; 208(4):345-59. PubMed ID: 5969585
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Correlation between catalepsy and dopamine decrease in the rat striatum induced by neuroleptics.
    Honma T, Fukushima H.
    Neuropharmacology; 1976 Oct; 15(10):601-7. PubMed ID: 1033478
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.